These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 27442357)

  • 1. Prenatal decision-making in the second and third trimester in trisomy 21-affected pregnancies.
    Weichert A; Braun T; Deutinger C; Henrich W; Kalache KD; Neymeyer J
    J Perinat Med; 2017 Feb; 45(2):205-211. PubMed ID: 27442357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parental decisions following prenatal diagnosis of sex chromosome aneuploidy in Hong Kong.
    So PL; Cheng KYY; Cheuk KY; Chiu WK; Mak SL; Mok SL; Lo TK; Yung WK; Lo FM; Chung HYB; Kan SYA; Lee CP; Tang HYM
    J Obstet Gynaecol Res; 2017 Dec; 43(12):1821-1829. PubMed ID: 28892214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The findings and sequence of events leading to termination of pregnancy due to Down's syndrome--before and after the verge of viability: 10 years experience at a single medical center].
    Baruchin O; Maymon R; Herman A; Tuvbin Y; Barel O; Zimerman A; Vaknin Z
    Harefuah; 2012 Nov; 151(11):602-6, 656. PubMed ID: 23367726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Termination of pregnancy following a Down Syndrome diagnosis: decision-making process and influential factors in a Muslim but secular country, Turkey.
    Adiyaman D; Atakul BK; Kuyucu M; Sahingoz Yildirim AG; Pala HG
    J Perinat Med; 2021 Feb; 49(2):170-177. PubMed ID: 32920541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decision making following a prenatal diagnosis of Down syndrome: an integrative review.
    Choi H; Van Riper M; Thoyre S
    J Midwifery Womens Health; 2012; 57(2):156-64. PubMed ID: 22432488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of ultrasound findings with decision to continue Down syndrome pregnancies.
    Perry S; Woodall AL; Pressman EK
    Community Genet; 2007; 10(4):227-30. PubMed ID: 17895628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on key techniques and intervention in reducing birth defects].
    Zhu BS; Su J; Lu XH; He J; Zhu S; Jiao CX; Zhang JM; Tang XH; Tao Y; Lin KP; Chen H; Li SY
    Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):658-63. PubMed ID: 22176989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal karyotyping after 28 weeks of gestation for late ultrasound findings in a low risk population.
    Drummond CL; Gomes DM; Senat MV; Audibert F; Dorion A; Ville Y
    Prenat Diagn; 2003 Dec; 23(13):1068-72. PubMed ID: 14691994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parental Decisions about Prenatal Screening and Diagnosis among Infants with Trisomy 21 in a National Cohort with High Uptake of Combined First-Trimester Screening.
    Miltoft CB; Wulff CB; Kjærgaard S; Ekelund CK; Tabor A;
    Fetal Diagn Ther; 2017; 41(3):209-214. PubMed ID: 27455074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of fetal diagnosis on the outcomes of second-trimester pregnancy termination for fetal abnormalities: a pilot study.
    Lo TK; Lau WL; Lai FK; Lam HS; Tse HY; Leung WC; Chin RK
    J Matern Fetal Neonatal Med; 2008 Aug; 21(8):523-7. PubMed ID: 18609362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ultrasound screening for Down syndrome and other chromosomal abnormalities by fetal nuchal translucency measurement between 11-14 weeks of gestation].
    Dimitrova V; Markov D; Chernev T; Karag'ozova Zh; Mazneĭkova V; Andonova S; Vŭzharova R
    Akush Ginekol (Sofiia); 2005; 44(1):32-7. PubMed ID: 15853009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid aneuploidy testing (knowing less) versus traditional karyotyping (knowing more) for advanced maternal age: what would be missed, who should decide?
    Leung WC; Lau ET; Lau WL; Tang R; Wong SF; Lau TK; Tse KT; Wong SF; To WK; Ng LK; Lao TT; Tang MH;
    Hong Kong Med J; 2008 Feb; 14(1):6-13. PubMed ID: 18239237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal detection of trisomy 21 by second-trimester ultrasound examination and maternal age in a non-selected population of 49 314 births in Norway.
    Offerdal K; Blaas HG; Eik-Nes SH
    Ultrasound Obstet Gynecol; 2008 Sep; 32(4):493-500. PubMed ID: 18688793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "This is the child we were given": A qualitative study of Danish parents' experiences of a prenatal Down syndrome diagnosis and their decision to continue the pregnancy.
    Lou S; Lanther MR; Hagenstjerne N; Bjørn Petersen O; Vogel I
    Sex Reprod Healthc; 2020 Mar; 23():100480. PubMed ID: 31733609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience.
    Spencer K; Nicolaides KH
    BJOG; 2003 Mar; 110(3):276-80. PubMed ID: 12628267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal hydrops and hepatosplenomegaly in the second half of pregnancy: a sign of myeloproliferative disorder in fetuses with trisomy 21.
    Smrcek JM; Baschat AA; Germer U; Gloeckner-Hofmann K; Gembruch U
    Ultrasound Obstet Gynecol; 2001 May; 17(5):403-9. PubMed ID: 11380964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evolving national birth prevalence of Down syndrome in Taiwan. A study on the impact of second-trimester maternal serum screening.
    Jou HJ; Kuo YS; Hsu JJ; Shyu MK; Hsieh TT; Hsieh FJ
    Prenat Diagn; 2005 Aug; 25(8):665-70. PubMed ID: 16049991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of parental decisions after the prenatal diagnosis of Down syndrome.
    Kramer RL; Jarve RK; Yaron Y; Johnson MP; Lampinen J; Kasperski SB; Evans MI
    Am J Med Genet; 1998 Sep; 79(3):172-4. PubMed ID: 9788556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second-trimester prenatal screening for trisomy 21 using biochemical markers: a 7-year experience in one cytogenetic laboratory.
    Marical H; Douet-Guilbert N; Bages K; Collet M; Le Bris MJ; Morel F; De Braekeleer M
    Prenat Diagn; 2006 Apr; 26(4):308-12. PubMed ID: 16491510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost effectiveness, the economic considerations of prenatal screening strategies for trisomy 21 in the Czech Republic.
    Dhaifalah I; Májek O
    Ceska Gynekol; 2012 Feb; 77(1):39-51. PubMed ID: 22536640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.